End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.07 CNY | -0.41% | +1.72% | -18.60% |
Apr. 15 | BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
Mar. 01 | BGI Genomics' 2023 Profit Falls 89% as Revenue Plunges 38% | MT |
Sales 2022 | 7.05B 972M | Sales 2023 | 4.35B 600M | Capitalization | 19.68B 2.72B |
---|---|---|---|---|---|
Net income 2022 | 803M 111M | Net income 2023 | 92M 12.7M | EV / Sales 2022 | 2.13 x |
Net cash position 2022 | 6.21B 857M | Net cash position 2023 | 5.12B 707M | EV / Sales 2023 | 3.35 x |
P/E ratio 2022 |
26.4
x | P/E ratio 2023 |
213
x | Employees | - |
Yield 2022 |
1.93% | Yield 2023 |
0.21% | Free-Float | 51.67% |
1 day | -0.41% | ||
1 week | +1.72% | ||
Current month | -4.54% | ||
1 month | -10.49% | ||
3 months | -5.35% | ||
6 months | -16.77% | ||
Current year | -18.60% |
Managers | Title | Age | Since |
---|---|---|---|
Li Jian Zhao
CEO | Chief Executive Officer | - | 21-06-15 |
Jian Hua Wang
FOU | Founder | 70 | - |
Yu Jue Wang
DFI | Director of Finance/CFO | 46 | 21-06-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jian Hua Wang
FOU | Founder | 70 | - |
Hong Tao Wang
BRD | Director/Board Member | - | 16-03-28 |
Ye Yin
BRD | Director/Board Member | 45 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 39.07 | -0.41% | 1,633,914 |
24-04-23 | 39.23 | +0.64% | 2,306,645 |
24-04-22 | 38.98 | +2.36% | 2,437,867 |
24-04-19 | 38.08 | -0.96% | 2,362,438 |
24-04-18 | 38.45 | +0.10% | 2,842,451 |
End-of-day quote Shenzhen S.E., April 23, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.60% | 2.05B | |
-14.52% | 11.48B | |
+44.03% | 3.27B | |
-33.09% | 2.2B | |
-27.59% | 1.49B | |
+17.10% | 1.01B | |
-3.06% | 743M | |
-33.50% | 413M | |
-46.94% | 377M | |
+27.44% | 374M |
- Stock Market
- Equities
- 300676 Stock